TD Asset Management
ACIU icon

TD Asset Management’s AC Immune ACIU Stock Holding History

TD Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28,900
Closed -$194K – 1494
2021
Q3 		$194K Buy
+28,900
New +$207K ﹤0.01% 1486
2019
Q1 		– Sell
-17,506
Closed -$165K – 1336
2018
Q4 		$165K Hold
17,506
– – ﹤0.01% 1360
2018
Q3 		$140K Buy
+17,506
New +$176K ﹤0.01% 1417

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TD Asset Management's ACIU Position: Q4 2021 in Review

TD Asset Management sold out of AC Immune (ACIU) in Q4 2021, closing a stake of 28,900 shares — an estimated $194K sold.

TD Asset Management first reported a position in ACIU in Q3 2018 and held it in 3 quarters. The position peaked at $194K in Q3 2021. 44 funds tracked by Wall St. Rank hold ACIU as of Q4 2021.

  • TD Asset Management reported no remaining AC Immune position as of Q4 2021 after selling out during the quarter.
  • TD Asset Management sold 28,900 AC Immune shares in Q4 2021, an estimated $194K.
  • TD Asset Management first reported a position in AC Immune in Q3 2018 and held it in 3 quarters.
  • TD Asset Management's AC Immune position peaked at $194K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held AC Immune as of Q4 2021.

Based on TD Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.